l-carnitine and prostate cancer Acetyl-l-carnitine is an anti-angiogenic agent
Acetyl l carnitine is an anti angiogenic agent targeting the VEGFR2 and CXCR4 pathways ScienceDirect Dysfunction of the carnitine cycle in tumor progression: Heliyon Frontiers Carnitine Traffic in Cells. Link With Cancer The carnitine system and cancer metabolic plasticity Cell Death & Disease acetyl l carnitine and prostate Acetyl L Carnitine downregulates invasion (CXCR4 CXCL12, MMP 9) angiogenesis (VEGF, CXCL8) pathways in cancer cells: rationale for prevention and interception strategies Journal of Experimental & Clinical Cancer Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy ACS Pharmacology & Translational Science
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





